News

June 24, 2025

Jack’s Tomorrow welcomes Michael J. Boland, PhD, to its Scientific Advisory Board

Jack’s Tomorrow is pleased to announce the addition of Michael J. Boland, PhD, to its Scientific Advisory Board. As a leading expert in developmental neurobiology and gene-targeted therapies, Dr. Boland brings unique expertise in support of Jack’s Tomorrow’s mission to accelerate research to find a treatment and cure for PURA Syndrome.

May 13, 2025

New mouse model paves way for research on PURA Syndrome, a neurogenetic disorder

Collaboration between The Jackson Laboratory and Jack’s Tomorrow advances a crucial step toward identifying potential treatments.

See the novel PURA mouse model infographic poster

February 25, 2025

Jack’s Tomorrow Welcomes Andrew Steinsapir, MBA, to its Scientific Advisory Board During Rare Disease Month 2025

December 17, 2024

New Collaboration with The Jackson Laboratory for Gene Overexpression Studies to Guide Future PURA Syndrome Therapeutics

July 16, 2024

Jack's Tomorrow Collaborates with The Jackson Laboratory Toward Finding Treatments for PURA Syndrome 

October 30, 2023

Jack’s Tomorrow Funds Research at Yale To Identify Molecular Therapies For Pura Syndrome

September 12, 2023

 Jack's Tomorrow Funds Research to Identify a Cure for PURA Syndrome